NASDAQ New 52-Week Highs And Lows
New Highs 121 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ ADMA Biologics ADMA 10.88 1,873,286
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Could Be 36% Below Their Intrinsic Value Estimate
Adma Biologics Insider Sold Shares Worth $2,548,580, According to a Recent SEC Filing
Adam S Grossman, Director, President,CEO, and Interim CFO, on June 14, 2024, sold 570,000 shares in Adma Biologics (ADMA) for $2,548,580. Following the Form 4 filing with the SEC, Grossman has control
This Insider Has Just Sold Shares In ADMA Biologics
Some ADMA Biologics, Inc. (NASDAQ:ADMA) shareholders may be a little concerned to see that the Co-Founder, Adam Grossman, recently sold a substantial US$1.1m worth of stock at a price of US$10.72 per
Form 144 | ADMA Biologics(ADMA.US) Officer Proposes to Sell 5.25 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $ADMA Biologics(ADMA.US)$ Officer Grossman Adam S intends to sell 500K shares of its common stock on Jun 14, with a total market value of approximately $5.25 million.
Catalyst Watch: HP Enterprise Event, Walmart+ Week, Pure Storage Buzz, and Triple-witching Volatility
Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin) Insights & Forecast 2024-2028, Featuring CSL, Grifols, Takeda Pharmaceutical, Octapharma, Kedrion & ADMA Biologics - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast (2024-2028)" report has been added to ResearchAndMarkets.com's o
An Intrinsic Calculation For ADMA Biologics, Inc. (NASDAQ:ADMA) Suggests It's 36% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, ADMA Biologics fair value estimate is US$16.48 ADMA Biologics' US$10.58 share price signals that it might be 36% undervalued The US$10.50
ADMA Biologics, Inc.'s (NASDAQ:ADMA) Share Price Boosted 53% But Its Business Prospects Need A Lift Too
Despite an already strong run, ADMA Biologics, Inc. (NASDAQ:ADMA) shares have been powering on, with a gain of 53% in the last thirty days.
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
ADMA Biologics First Quarter 2024 Earnings: Beats Expectations
ADMA Biologics Hits 52-week High on Q1 Beat, Guidance Raise
ADMA Biologics Inc (ADMA) Surpasses Analyst Revenue and Earnings Forecasts in Q1 2024
ADMA Biologics Price Target Raised to $10.00/Share From $8.00 by Raymond James
ADMA Biologics Price Target Raised to $10.00/Share From $8.00 by Raymond James
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Diodes posted adjusted earnings of 28 cents
Express News | Cantor Fitzgerald Maintains Overweight on ADMA Biologics, Raises Price Target to $10
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
U.S. stocks were mostly higher, with the Dow Jones gaining over 100 points on Friday.
ADMA Biologics Up Over 24%, on Track for Highest Close Since December 2015 -- Data Talk
ADMA Biologics, Inc. (ADMA) is currently at $8.62, up $1.70 or 24.46% --Would be highest close since Dec. 14, 2015, when it closed at $8.63 --On pace for largest percent increase since Nov. 10, 2022
Novavax, Macrogenics, Biofrontera Among Healthcare Movers
Earnings Call Summary | ADMA Biologics(ADMA.US) Q1 2024 Earnings Conference
The following is a summary of the ADMA Biologics, Inc. (ADMA) Q1 2024 Earnings Call Transcript:Financial Performance:ADMA Biologics reported a Q1 2024 revenue of $81.9 million, indicating an increase
No Data